Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis

Journal of Gastroenterology

Volumn 35, Issue 3, 2000, Pages 226-234

  Matsuo, Isao ^a   Ikuno, Nobuhiro ^a   Omagari, Katsuhisa ^a   Kinoshita, Hideki ^a   Oka, Mikio ^a   Yamaguchi, Hiroyuki ^a   Kohno, Shigeru ^a   Mackay, Ian R ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Aqueou two phase partition; Enhanced chemiluminescence; Hepatocyte plasma membrane; Immunoblotting; Liver membrane antigens; Type 1 autoimmune hepatitis

Indexed keywords

ANTINUCLEAR ANTIBODY; MEMBRANE ANTIGEN; PREDNISOLONE;

ADULT; AGED; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; CHEMOLUMINESCENCE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIVER CELL MEMBRANE; LIVER MEMBRANE; MALE; MOLECULAR SIZE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE SPECIFICITY; TITRIMETRY;

EID: 0034039208     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050335     Document Type: Article

References (24)

1. Mackay IR. The grey edges of autoimmune hepatitis. Int Hepatol Commun 1996;5:191-200.
2. Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995;90:1206-11.
3. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
4. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxigenase. J Clin Invest 1991;88:1370-8.
5. Frazer IH, Jordan TW, Collins EC, Andrews P, Mackay IR. Antibody to liver membrane antigens in chronic active hepatitis. IV. Exclusion of specific reactivity to polypeptides and glycolipids by immunoblotting. Hepatology 1987;7:4-10.
6. Swanson NR, Reed WD, Yarred LJ, Shilkin KB, Joske RA. Autoantibodies to isolated human hepatocyte plasma membranes in chronic active hepatitis. II. Specificity of antibodies. Hepatology 1990;11:613-21.
7. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
8. Morre DJ, Morre DM. Preparation of mammalian plasma membranes by aqueous two-phase partition. Biotechniques 1989,7: 946-58.
9. +-activated p-nitrophenylphosphatase activities of NaI-treated microsomes from young rat cerebrum. J Biol Chem 1979;254: 4577-84.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
11. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76: 4350-4.
12. Nishioka M. Nuclear antigens in autoimmune hepatitis. In: Meyer zum Buschenfelde K-H, Hoofnagle J, Manns M, editors. Immunology and liver. Dordrecht: Kluwer Academic Publishers; 1993. p. 193-205.
13. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-89.
14. Fusconi M, Cassani F, Zauli D, Lenzi M, Ballardini G, Volta U, et al. Anti-actin antibodies: a new test for an old problem. J Immunol Methods 1990;130:1-8.
15. Manns M, Meyer zum Buschenfelde K-H, Hess G. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease specificity. Gut 1980;21:955-61.
16. Toda G, Ikeda Y, Hashimoto N, Yamazaki M, Torii M, Oka H. Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases. Clin Exp Immunol 1983;54:661-70.
17. Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 1994; 107:799-804.
18. Hopf U, Jahn H-U, Moller B, Stemerowicz R, Wittenbrink C, Klein R, et al. Liver membrane antibodies (LMA) recognize a 26-kD protein on the hepatocellular surface. Clin Exp Immunol 1990;79:54-61.
19. Chen Q-Y, Mackay IR, Fida S, Myers MA, Rowley MJ. Natural and disease-associated autoantibodies to the autoantigen dihydrolipoamide acetyltransferase recognize different epitopes. J Autoimmun 1998;11:151-61.
20. Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 1997;26:1054-66.
21. Zhang B, Lan MS, Notkins AL. Autoantibodies to IA-2 in IDDM: location of major antigenic determinants. Diabetes 1997; 46:40-3.
22. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde K-H. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;1:292-4.
23. Wesierska-Gadek J, Grimm R, Hitchman E, Penner E. Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 1998;114:329-35.
24. Lapierre P, Hajoui O, Homberg J-C, Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999;116:643-9.